Guan, Xin, Luying Wang, Yang Cao, Fenghao Shi, He Xu, Jie Ding, Meiyu Wu, and Hongchao Li. “A Erratum on Cost Effectiveness Analysis of Blonanserin Versus Ziprasidone As First-Line Treatment for Patients With Schizophrenia in China”. Health Decision 1 (November 24, 2023). Accessed May 11, 2024. https://www.hksmp.com/journals/hd/article/view/498.